As of Apr 25
| +0.17 / +0.48%|
The 31 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 38.84, with a high estimate of 54.20 and a low estimate of 25.83. The median estimate represents a +10.07% increase from the last price of 35.29.
The current consensus among 35 polled investment analysts is to Buy stock in AstraZeneca PLC. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.